• 

  April 5, 2026

  Canada Just Bet Another $280M on Bioprinted Medicines, Here’s What It Means for the Industry

  R.D. Solorzano

• 

  March 8, 2026

  UC San Diego’s ARPA-H Project Targets the A Different Approach for the Bioprinted LIVER Program

  R.D. Solorzano

• 

  March 6, 2026

  Japan Moves Toward First Commercial iPS Cell Therapies

  R.D. Solorzano

• 

  March 3, 2026

  Cellares Raises $257M to Industrialize Cell Therapy Manufacturing

  R.D. Solorzano

• 

  February 20, 2026

  United Therapeutics Reports Breakthrough Phase 1 Results for Bioengineered Liver Support System

  R.D. Solorzano

• 

  February 16, 2026

  Aspect Biosystems and Novo Nordisk Deepen Partnership to Advance Curative Diabetes Therapies

  R.D. Solorzano

• 

  September 22, 2025

  Humacyte Reports Positive Data on Bioengineered Vessels for Vascular Repair and Coronary Bypass

  R.D. Solorzano

• 

  September 22, 2025

  eGenesis Wins FDA Green Light for Gene-Edited Pig Kidney Trial

  R.D. Solorzano

• 

  August 25, 2025

  Terumo Acquires OrganOx for $1.5 Billion: A Landmark Deal in Organ Preservation and Transplantation

  R.D. Solorzano

• 

  August 8, 2025

  Instant Collagen, Real-Time Biofabrication: What TRACE Means for the Lab & the Market

  R.D. Solorzano